{"id":"https://openalex.org/W7051653129","doi":null,"title":"Planejamento de candidatos a f\u00e1rmacos multialvo inibidores de Acetilcolinesterase (AChE) e glicog\u00eanio sintase quinase-3\u03b2 (GSK-3\u03b2) para tratamento da doen\u00e7a de Alzheimer","display_name":"Planejamento de candidatos a f\u00e1rmacos multialvo inibidores de Acetilcolinesterase (AChE) e glicog\u00eanio sintase quinase-3\u03b2 (GSK-3\u03b2) para tratamento da doen\u00e7a de Alzheimer","alternate_titles":[],"publication_year":2020,"publication_date":"2020-02-12","ids":{"openalex":"https://openalex.org/W7051653129"},"language":"en","primary_location":{"id":"pmh:oai:repositorio.unifap.br:123456789/337","doi":null,"is_oa":true,"landing_page_url":"http://repositorio.unifap.br:80/jspui/handle/123456789/337","pdf_url":null,"source":{"id":"https://openalex.org/S4306402641","display_name":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Cient\u00edficas)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4383465926","host_organization_name":"LA Referencia","host_organization_lineage":["https://openalex.org/I4383465926"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"1 CD-ROM","raw_type":"info:eu-repo/semantics/masterThesis"},"parent_works":[],"lineage":["https://openalex.org/W7051653129"],"child_works_count":0,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://repositorio.unifap.br:80/jspui/handle/123456789/337","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007662948","display_name":"Leide Caroline dos Santos Pican\u00e7o","orcid":"https://orcid.org/0000-0001-7710-0243","observed_orcids":["https://orcid.org/0000-0001-7710-0243"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"PICAN\u00c7O, Leide Caroline dos Santos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5007662948"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.9603999853134155,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.9603999853134155,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.03180000185966492,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.006500000134110451,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9959999918937683},{"id":"https://openalex.org/keywords/acetylcholinesterase-inhibitors","display_name":"acetylcholinesterase inhibitors","score":0.9079999923706055},{"id":"https://openalex.org/keywords/glycogen-synthase-kinase-3beta-inhibitor","display_name":"glycogen synthase kinase-3\u03b2 inhibitor","score":0.9120000004768372},{"id":"https://openalex.org/keywords/multi-target-drug-design","display_name":"multi-target drug design","score":0.8479999899864197},{"id":"https://openalex.org/keywords/hybrid-molecules","display_name":"hybrid molecules","score":0.574999988079071},{"id":"https://openalex.org/keywords/physostigmine","display_name":"physostigmine","score":0.9440000057220459},{"id":"https://openalex.org/keywords/luteolin","display_name":"luteolin","score":1.0},{"id":"https://openalex.org/keywords/pharmacophore-modeling","display_name":"pharmacophore modeling","score":0.8709999918937683},{"id":"https://openalex.org/keywords/pharmacokinetic-prediction","display_name":"pharmacokinetic prediction","score":0.8289999961853027},{"id":"https://openalex.org/keywords/toxicity-assessment","display_name":"toxicity prediction","score":0.9210000038146973},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.5730000138282776},{"id":"https://openalex.org/keywords/anti-alzheimer-activity","display_name":"anti-Alzheimer activity","score":0.6970000267028809}],"concepts":[{"id":"https://openalex.org/C56173144","wikidata":"https://www.wikidata.org/wiki/Q1539893","display_name":"Pharmacophore","level":2,"score":0.8442999720573425},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7182000279426575},{"id":"https://openalex.org/C2778816929","wikidata":"https://www.wikidata.org/wiki/Q22676679","display_name":"Acetylcholinesterase","level":3,"score":0.5412999987602234},{"id":"https://openalex.org/C2779484449","wikidata":"https://www.wikidata.org/wiki/Q412189","display_name":"Memantine","level":4,"score":0.5194000005722046},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.484499990940094},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.47749999165534973},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4530999958515167},{"id":"https://openalex.org/C192071366","wikidata":"https://www.wikidata.org/wiki/Q2991682","display_name":"Drug design","level":2,"score":0.44920000433921814},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.4390999972820282},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.43779999017715454},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.4205999970436096},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.40639999508857727},{"id":"https://openalex.org/C178910836","wikidata":"https://www.wikidata.org/wiki/Q2196961","display_name":"Molecular model","level":2,"score":0.36640000343322754},{"id":"https://openalex.org/C2776980637","wikidata":"https://www.wikidata.org/wiki/Q427492","display_name":"Enzyme inhibitor","level":3,"score":0.3336000144481659},{"id":"https://openalex.org/C53105671","wikidata":"https://www.wikidata.org/wiki/Q14777816","display_name":"Rational design","level":2,"score":0.32899999618530273},{"id":"https://openalex.org/C41183919","wikidata":"https://www.wikidata.org/wiki/Q423026","display_name":"Active site","level":3,"score":0.3001999855041504},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.2928999960422516},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.2849000096321106},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.26820001006126404},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.2669999897480011},{"id":"https://openalex.org/C39398028","wikidata":"https://www.wikidata.org/wiki/Q18028862","display_name":"Monoamine oxidase B","level":4,"score":0.2630999982357025},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.2558000087738037}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:repositorio.unifap.br:123456789/337","doi":null,"is_oa":true,"landing_page_url":"http://repositorio.unifap.br:80/jspui/handle/123456789/337","pdf_url":null,"source":{"id":"https://openalex.org/S4306402641","display_name":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Cient\u00edficas)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4383465926","host_organization_name":"LA Referencia","host_organization_lineage":["https://openalex.org/I4383465926"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"1 CD-ROM","raw_type":"info:eu-repo/semantics/masterThesis"}],"best_oa_location":{"id":"pmh:oai:repositorio.unifap.br:123456789/337","doi":null,"is_oa":true,"landing_page_url":"http://repositorio.unifap.br:80/jspui/handle/123456789/337","pdf_url":null,"source":{"id":"https://openalex.org/S4306402641","display_name":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Cient\u00edficas)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4383465926","host_organization_name":"LA Referencia","host_organization_lineage":["https://openalex.org/I4383465926"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"1 CD-ROM","raw_type":"info:eu-repo/semantics/masterThesis"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9789000153541565}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4389154183","https://openalex.org/W2786033877","https://openalex.org/W7164986488","https://openalex.org/W4398148485","https://openalex.org/W4391642832","https://openalex.org/W4399492986","https://openalex.org/W4297535914","https://openalex.org/W7165466654","https://openalex.org/W3080958518","https://openalex.org/W7160438867"],"abstract_inverted_index":{"Introduction:":[0],"Alzheimer's":[1],"disease":[2],"(AD)":[3],"is":[4],"characterized":[5],"by":[6],"appearance":[7],"of":[8,58,106,126,152,189,208],"senile":[9],"plaques":[10],"and":[11,17,108,128,131,137,142,145,166,175,181,192,200,224,232,240,248,255,257,260,267],"neurofibillary":[12],"tangles.":[13],"Acetylcholinesterase":[14],"inhibitors":[15,38],"(AChEI)":[16],"memantine":[18],"are":[19],"used":[20],"as":[21,34,185,264],"treatment,":[22],"however,":[23],"other":[24],"therapeutic":[25],"alternatives":[26],"for":[27,69,187,245],"AD":[28,70],"treatment":[29],"has":[30,50],"been":[31],"searched,":[32],"such":[33],"Glycogen":[35],"Synthase":[36],"Kinase-3\u03b2":[37],"(GSK-3\u03b2I).":[39],"Although,":[40],"one-target":[41],"drugs":[42,194,269],"can":[43],"not":[44],"always":[45],"modify":[46],"complex":[47],"systems,":[48],"which":[49],"several":[51],"pathological":[52],"mechanisms.":[53],"Objectives:":[54],"Therefore,":[55,252],"the":[56,87,96,114,123,227],"aim":[57],"this":[59],"research":[60],"was":[61,84,93,111,120],"to":[62],"design":[63,188],"new":[64,190],"AChEI-GSK-3\u03b2I":[65,268],"multi-target":[66],"drug":[67],"candidates":[68,270],"treatment.":[71],"Methodology:":[72],"Initially,":[73],"13":[74],"compunds":[75],"with":[76,157],"proven":[77],"anti-Alzheimer":[78,214],"activity":[79],"were":[80,101,148,161,183,204,262],"selected.":[81],"Molecular":[82],"docking":[83,134],"performed":[85,121],"using":[86,103,113],"GOLD":[88],"program.":[89,116],"Subsequently,":[90],"pharmacophoric":[91,159],"modeling":[92],"derived":[94],"from":[95],"PharmaGist":[97],"webserver.":[98],"Pharmacokinetic":[99],"properties":[100],"computed":[102],"QikProp":[104],"module":[105],"Schr\u00f6dinger":[107],"toxicity":[109],"profile":[110],"evaluated":[112],"DEREK":[115],"Finally,":[117],"molecular":[118],"hybridization":[119],"between":[122,140],"structural":[124],"subunits":[125],"AChEI":[127,191,266],"GSK-3\u03b2I.":[129],"Results":[130],"discussion:":[132],"In":[133,150,206,216],"study,":[135],"hydrogen":[136,168],"hydrophobic":[138],"interactions":[139],"AChE":[141,247],"GSK-3\u03b2":[143,249],"enzymes":[144],"selected":[146],"compounds":[147],"observed.":[149],"derivation":[151],"pharmacophore":[153],"group,":[154],"8":[155,239,261],"molecules":[156],"3":[158],"points":[160],"aligned:":[162],"one":[163],"aromatic":[164],"rings":[165],"two":[167],"bond":[169],"acceptors.":[170],"Inhibitors":[171],"demonstrated":[172],"good":[173],"pharmacokinetic":[174,231],"toxicological":[176,233],"prediction":[177,207],"results.":[178],"After,":[179],"Physostigmine":[180],"Luteolin":[182],"chosen":[184,263],"prototypes":[186],"GSK-3\u03b2I":[193],"candidates.":[195],"9":[196,211,241],"proposals,":[197],"5":[198,225],"AChEIs":[199],"4":[201],"hybrids":[202,236],"AChEI-GSKI-3\u03b2":[203],"designed.":[205],"biological":[209],"activity,":[210],"proposals":[212,221,253],"exhibited":[213],"activity.":[215],"addition,":[217],"results":[218,229],"showed":[219],"that":[220],"1,":[222],"2":[223,256],"obtained":[226],"best":[228],"in":[230],"predictions,":[234],"still":[235],"6,":[237],"7,":[238],"presented":[242],"higher":[243],"affinity":[244],"both":[246],"enzymes.":[250],"Conclusions:":[251],"1":[254],"Hybrids":[258],"6":[259],"potent":[265]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7051653129","counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-10-10T00:00:00"}
